![]() |
|
|
U.S. Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58202
3To whom correspondence should be addressed. E-mail: hlukaski{at}gfhnrc.ars.usda.gov.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: cellular magnesium magnesium retention oxygen uptake heart rate humans
| INTRODUCTION |
|---|
|
|
|---|
Despite our knowledge of the fundamental and integrative roles that magnesium plays in the maintenance of biological function, attempts to identify functional consequences of dietary magnesium deficiency in humans are limited. In normal adults, experimental magnesium deficiency results in altered cardiovascular function, including hypertension and electrocardiographic abnormalities (2
,3
), and impaired carbohydrate metabolism with insulin resistance and decreased insulin secretion (2
,4
). Epidemiologic data tend to confirm these initial findings (5
,6
). Conflicting data, however, emerge from magnesium intervention trials of patients with documented cardiovascular disease (7
). Some of the inconsistencies may be explained by uncontrolled variables such as predisposing conditions that limit magnesium intake or absorption, or promote excretion.
Dietary magnesium generally does not meet recommended intakes for adults. Results of a recent national survey in the United States indicate that a substantial proportion of women do not consume the recommended daily intake of magnesium; this problem increases among women >50 y old (8
). The average magnesium intake for women is 228 mg/d compared with the recommendation of 320 mg/d (8
). The average intake estimate is derived from 1-d diet recall and thus may overestimate actual magnesium intake (9
).
Magnesium also has been proposed as a limiting nutrient for exercise and physical performance (10
13
). Surveys of physically active individuals indicate that magnesium intakes among certain groups of athletes do not meet recommendations for adults (14
). A few reports indicate that magnesium supplementation enhances strength gain (15
) and improves exercise performance (16
,17
). However, it is unclear whether these improvements in performance are related to remediation of an existing magnesium deficiency or a pharmacologic effect (18
).
The present study was designed to test the hypothesis that restricted dietary magnesium elicits alterations in biochemical indicators of magnesium status, magnesium retention and functional responses to controlled exercise in postmenopausal women.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Postmenopausal women (n = 12) participated in a magnesium depletion-repletion study. Two of the women did not complete all of the nutritional, biochemical and physiologic tests; data are reported only for the 10 women who accomplished all tests. Upon arrival at the Grand Forks Human Nutrition Research Center, the women began a 35-d equilibration or control period during which they consumed a basal diet supplemented with 200 mg magnesium/d. A magnesium-depletion period of 93 d followed in which only the basal, low magnesium diet was fed. This low magnesium diet supplied 112 mg of magnesium when an 8.4 MJ (2000 kcal) intake was consumed. The study concluded with a magnesium repletion period of 49 d in which the low magnesium diet was supplemented with 200 mg of magnesium daily. Phlebotomy and collection of excreta for determination of magnesium retention were performed at regular intervals during the study. Physiologic testing and skeletal muscle biopsies were performed during the last 12 d of each experimental period to permit adaptation to the dietary treatment.
Postmenopausal women (n = 10) aged (mean ± SEM) 59.7 ± 2.7 y (range, 44.971.0 y), with a mean body weight of 69.1 ± 3.5 kg (range, 51.991.5 kg) and a body mass index of 26.3 ± 0.8 kg/m2 (range, 22.232.7 kg/m2) completed all aspects of the study. The women were recruited through public advertisements and selected after medical, nutritional and psychological evaluations established that they had no underlying disease, and were emotionally suited to participate in the clinical research project. They neither received hormone replacement therapy nor participated in physical training, but did participate irregularly in recreational activities. The participants gave their written informed consent to participate in this study, which was approved for human subjects by the Institutional Review Board of the University of North Dakota and by the Human Studies Review Committee of the USDA. The volunteers resided in the metabolic unit of the Grand Forks Human Nutrition Research Center under close supervision 24 h/d, 7 d/wk; they consumed only food and beverages provided by the dietary staff and collected all excreta. When outside of the Unit, the women were chaperoned by trained staff members.
Registered dietitians planned the basal low magnesium diet that was based on ordinary Western foods presented in a 3-d rotating menu cycle (Table 1
). The energy distribution of the diet was 10% protein, 35% fat and 55% carbohydrate, which is consistent with the diet composition of the average adult in the United States (19
). This basal, low magnesium diet was calculated (20
) to supply
700 mg calcium, 11.25 µg cholecalciferol, 2.4 mg copper, and 94 mg magnesium when a 8.48 MJ (2000 kcal) intake was consumed. The calcium content of the diet also was consistent with normal calcium intakes of women in the United States (8
) and has been shown to maintain calcium balance in postmenopausal women (21
). The diet was adequate in other essential nutrients.
|
The dietary intake of each woman was based on her energy needs as calculated by using the Harris-Benedict equation (22
) plus an additional 50% of basal energy expenditure for normal physical activity. Body weight was maintained within ± 2% of individual values determined at the end of the control period by use of individualized exercise prescriptions and modest changes in food intake in 0.85-MJ (200-kcal) increments. Changes in food intake resulted in proportional changes in nutrient intakes.
Venous blood was taken by phlebotomy and limited to
250 mL/mo for routine health assessment and determination of magnesium status. Blood was drawn into plastic syringes from an antecubital vein, which had been made visible by temporary use of a tourniquet, after the volunteers had fasted for 10 h. Serum was processed within 90 min of the time the blood was drawn. Serum magnesium was determined by flame atomic absorption spectrometry (AAS)4
after dilution with a 0.5% solution of lanthanum oxide in deionized water (23
). Concurrent analysis of Sera Chem controls (Fisher Scientific, Orangeberg, NY) yielded values of 0.93 ± 0.05 (mean ± SD) mmol/L (2.26 ± 0.11 mg/dL; n = 55) and 1.73 ± 0.11 mmol/L (4.20 ± 0.27 mg/d; n = 60) compared with certified values of 0.97 ± 0.34 mmol/L (2.36 ± 0.83 mg/dL) and 1.81 ± 0.49 mmol/L (4.40 ± 1.2 mg/dL), respectively. RBC magnesium was determined by using AAS after removal of platelet-rich plasma and digestion of erythrocytes with nitric acid and peroxide (24
).
All food was weighed with an accuracy of 0.1 g during preparation in the metabolic kitchen and was consumed quantitatively by all volunteers. Urine and feces were collected carefully to avoid trace mineral contamination. Duplicate diets at the 10.6 MJ (2500 kcal) intake were prepared daily for analysis and were blended in a plastic blender with stainless steel blades. Adjustments for differences in individual energy intakes were calculated proportionately.
The magnesium content of 3-d composites of diets and feces was determined by inductively coupled plasma emission spectroscopy [ICAP; Jarrell-Ash, Waltham, MA; (25
)] after wet digestion of aliquots of freeze-dried, blended material with nitric and perchloric acids (26
). Urinary magnesium was determined by ICAP analysis of a diluted aliquot (25
). Concurrent replicate analysis of a Total Diet SRM #1548 (n = 9) (National Institute of Standards and Technology, Gaithersburg, MD) yielded a value of 533 ± 10 (mean ± SD) µg/g compared with a certified value of 556 ± 27 µg/g. Replicate analysis of standard bovine liver SRM #1577a (n = 14) yielded a value of 612 ± 18 µg/g compared with a certified value of 600 ± 14 µg/g. Magnesium balance or retention was calculated as the difference between intake and excretion (feces plus urine) for 3-d periods continuously throughout the study.
Cellular magnesium status was assessed by measurement of the magnesium concentration of skeletal muscle obtained by using percutaneous muscle biopsy of the vastus lateralis muscle of one leg. A total of three biopsies were performed, the first and third on one leg and the second on the other leg. A single biopsy specimen was obtained during the last 12 d of each experimental period according to Bergstrom (27
);
3040 mg of muscle tissue was obtained from each biopsy. After adipose and connective tissue were dissected from each specimen, the specimen was rinsed with distilled-deionized water and blotted dry. The samples were placed in clean teflon tubes and dried to constant weight at 50°C. The samples were digested in 250 µL of Vycor distilled nitric acid (GFS Chemicals, Columbus, OH) in a sand bath until they were nearly dry. The cooled, digested samples were diluted to 1.0 mL final volume with 2% Vycor distilled nitric acid. Magnesium was determined in the digestates by ICAP analysis. Concurrent analysis of standard bovine liver SRM# 1577a (n = 10) (National Institute of Standards and Technology) yielded a value of 615 ± 14 µg/g, compared with a certified value of 601 ± 28 µg/g. Muscle magnesium concentration was expressed as mmol/kg dry weight.
Metabolic responses at rest and during submaximal work.
Submaximal work capacity was determined by using a cycle ergometer (Monark; Varberg, Sweden) and a continuous, progressive exercise protocol that was terminated when the volunteer reached a heart rate of 80% of age-adjusted peak heart rate [e.g., 0.8 (220 - age)]. Exercise tests were performed at the end of each dietary period. After an overnight fast, the women rested for 5 min while seated on the ergocycle, then pedaled at 50 revolutions/min starting with an initial external resistance of 0 W, then increasing by 25-W increments every 3 min until the target heart rate was attained (see below) and the test was terminated. Heart rate was monitored continuously during the preexercise and exercise periods by using standard electrocardiographic leads (II, aVF and CM5), and was recorded during the last 10 s of each minute with a multichannel recorder. Oxygen uptake and carbon dioxide output were determined at rest and during exercise with indirect calorimetry (28
) every 2 s with an automated system (Q Plex I; Quinton Instruments, Seattle, WA). The oxygen and carbon dioxide analyzers were calibrated before each test with reference gas mixtures whose composition was previously determined by standard chemical procedures. The oxygen consumption and carbon dioxide data were presented as an average value per minute.
During the control period, each woman participated in three separate bouts of ergocycle testing on different days to become familiar with the equipment and the test protocol. The peak power output of each volunteer was recorded and was used as the termination point for all subsequent submaximal exercise tests. The test-retest reproducibility of the physiologic responses to this end point was ± 2% for heart rate, oxygen uptake and carbon dioxide output. To preserve familiarity with the ergocycle and to ensure the maintenance of aerobic capacity and body composition, each woman received an individualized ergocycle exercise prescription based on an intensity of 50% peak power output and performed for three 15-min sessions weekly on nonconsecutive days (29
).
Some indirect estimates of energy utilization were calculated. Gross or total oxygen uptake was calculated as the sum of minute oxygen uptake during each exercise test. Cumulative net oxygen uptake was determined as the sum of each minute oxygen consumption corrected for resting oxygen uptake (30
).
Data are presented as the mean ± SEM The effect of dietary magnesium on biochemical, nutritional and physiologic responses was assessed by repeated-measures ANOVA (31
). When a significant main effect was identified, comparisons among dietary magnesium intakes were made with Tukey-Kramer contrasts with adjustments for multiple comparisons (31
). A paired t test was used to determine whether retention or balance data were different than 0 (31
).
| RESULTS |
|---|
|
|
|---|
Magnesium intake, excretion and balance.
Dietary magnesium increased significantly during the depletion and repletion periods (Table 2
). The increase was attributed principally to an unanticipated change by the manufacturer in the anticaking agent of the beverage mix, which increased the magnesium content (3040 mg/d) of the diet that was used in the depletion and repletion periods for all volunteers, as well as a modest increase in the food intake (0.85 MJ/d or 200 kcal/d) required to maintain body weights of three of the women.
|
Magnesium balance decreased significantly (e.g., net loss of magnesium of -42 mg/d) during magnesium depletion compared with a net retention (+ 32 and + 38 mg/d) when dietary magnesium was adequate. Magnesium balances were different (P < 0.05) than 0.
Blood biochemical and cellular measures of magnesium status.
Serum magnesium concentrations were within the range of normal values and showed slight responses to changes in dietary magnesium (Fig. 1
). Compared with the control period, serum magnesium tended to decrease (P = 0.07) from 0.85 ± 0.02 to 0.81 ± 0.02 mmol/L with restricted magnesium intake and then increase (P = 0.06) to 0.86 ± 0.02 mmol/L with magnesium repletion. Erythrocyte magnesium concentration decreased (P < 0.05) when dietary magnesium was low [5.91 ± 0.07 µmol/g hemoglobin (Hb)] and increased when magnesium intake was greater during the control and repletion periods (6.74 ± 0.08 and 6.68 ± 0.08 µmol/g Hb).
|
Functional responses during submaximal exercise.
The duration of submaximal ergocycle exercise and hence total work was maintained despite dietary magnesium restriction. Magnesium intake, however, affected metabolic and cardiovascular responses during exercise (Table 3
). Peak oxygen uptake, total and cumulative net oxygen utilization and heart rate increased significantly during magnesium restriction compared with the periods when magnesium intake was adequate.
|
| DISCUSSION |
|---|
|
|
|---|
Functional deficits associated with magnesium deprivation are well characterized. Severe magnesium deficiency in humans results in neuromuscular dysfunction (34
). Functional deficits with moderate magnesium depletion are not well characterized. The results of the present study show that low dietary magnesium, in amounts consumed by some women in the United States, is associated with an overall loss of magnesium from the body, decreased cellular magnesium, serum magnesium in the low end of the range of normal values and decreased work economy during submaximal work. The finding of impaired work economy (increased oxygen utilization to accomplish the same work output) is consistent with some previous results (11
,12
) in physically active adults and elite athletes and, therefore, provides evidence for a role of magnesium in physical activity.
Reports of decreased magnesium intake and reduced serum magnesium concentrations within the range of normal values in some groups of physically active persons heighten interest in the role of magnesium in physical training and performance (14
,37
,38
). Evidence of impaired physiological function during physical activity or exercise performance and documented magnesium depletion or deficiency, however, is sparse (18
,39
).
Magnesium supplementation of humans has yielded inconsistent reports of improved exercise metabolism and performance. In a double-blind, crossover trial, magnesium supplementation (390 mg/d for 25 d with a 3-wk washout) of male athletes resulted in increased peak oxygen uptake and total work output during work capacity tests (3
). During submaximal work, supplemental magnesium elicited reductions in heart rate, ventilation, oxygen uptake and carbon dioxide production (40
). Physically active collegians experienced significant increases in endurance performance and decreased oxygen utilization during standardized, submaximal exercise after magnesium supplementation at 8 mg/(kg · d) (17
). Similarly, men supplemented with magnesium (420 mg/d) had significant strength gains during resistance training compared with their unsupplemented counterparts consuming 250 mg magnesium daily (15
). In contrast, other studies have found no functional or performance improvements resulting from magnesium supplementation of physically active persons with serum magnesium and muscle magnesium concentrations in the range of normal values (18
,39
). The contradictory response in function and performance to magnesium supplementation apparently reflects differences in the magnesium nutritional status of the participants.
Supplementation of magnesium-depleted individuals consistently results in significant improvements in physiologic function and some measures of performance. After magnesium supplementation of 360 mg/d for 3 wk, female competitive athletes with low plasma magnesium concentrations within the range of normal values responded with significant decreases in circulating total creatine kinase and the creatine kinase isozyme from skeletal muscle after training, compared with other low magnesium status athletes receiving a placebo (11
). Similarly, elite male rowers supplemented with 360 mg of magnesium daily for 4 wk used less oxygen during a controlled rowing test compared with other rowers receiving a placebo (41
).
The findings of the present study confirm the impaired cardiorespiratory and cardiovascular function during submaximal work when dietary magnesium was limited and demonstrate for the first time that the impairments were associated with magnesium depletion. Thus, this report provides the first evidence that low dietary magnesium, in amounts consumed by some groups of physically active individuals, impairs function during conditions of increased energy expenditure and that functional limitations occur despite the level of physical fitness (e.g., trained athletes vs. relatively sedentary postmenopausal women).
Magnesium depletion may elicit impaired work economy by diverse mechanisms. In rats, decreased skeletal muscle magnesium and serum magnesium caused a partial uncoupling of the respiratory chain in liver mitochondria with a reduced ADP to oxygen ratio (42
). Similar effects of magnesium deficiency on mitochondrial respiratory chain have been described in heart muscle cells (43
). Thus, magnesium depletion increases the oxygen requirement to maintain ATP production.
Magnesium depletion may increase the energy cost of muscle contraction. Ergocycle work is a combination of muscle contraction and relaxation. Relaxation accounts for an important fraction of total energy needs during the short, repeated muscle contractions associated with pedaling a cycle ergometer (44
). We hypothesize that the hyperexcitability of magnesium deficiency (1
) boosts the energy cost, and hence oxygen use, of cycling by increasing the cocontraction activity of agonist and antagonist muscles and decreasing muscle relaxation during submaximal work. Therefore, the combination of augmented mitochondrial respiratory activity and enhanced neuromuscular excitability may explain the increased oxygen requirement during controlled exercise observed in the present study.
The chemical balance data from the present study are consistent with the recent dietary recommendations for magnesium intake in women aged 5170 y (7
). The estimated average requirement (EAR) for magnesium for older women is based on an extrapolation of the balance data of 10 women, aged 2553 y, who consumed self-selected diets ranging from 164 to 301 mg/d in magnesium intake with an average intake of 231 ± 80 mg/d (35
). The EAR for magnesium was estimated to be 265 mg/d on the basis of the anticipated decline in renal function with aging (7
). The estimate for a recommended dietary allowance (RDA) of magnesium is 320 mg/d (7
), which is similar to the value of 322 mg/d determined in the present study. Importantly, the findings of altered cardiorespiratory function at low dietary magnesium intake provide independent confirmation of the current RDA for magnesium in older women.
In conclusion, the present study demonstrates that magnesium depletion may be induced by dietary magnesium restriction in otherwise healthy postmenopausal women. It provides independent data that support the current RDA for magnesium for women aged 5170 y on the basis of various experimental approaches including chemical balance, biochemical and functional markers. The decreased work economy as a functional impairment of restricted dietary magnesium is unique and extends preliminary observations in young elite athletes, in whom magnesium status was not examined, to older women not participating in intense physical activity.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 U.S. Department of Agriculture, Agricultural Research Service, Northern Plains Area is an equal opportunity/affirmative action employer and all agency services are available without discrimination. Mention of a trademark or proprietary product does not constitute a guarantee of warranty of the product by the U.S. Department of Agriculture and does not imply its approval to the exclusion of other products that may also be suitable. ![]()
4 Abbreviations used: AAS, atomic absorption spectrometry; EAR, estimated average requirement; Hb, hemoglobin; ICAP, inductively coupled plasma emission spectroscopy; RDA, recommended dietary allowance. ![]()
Manuscript received 7 December 2001. Initial review completed 7 January 2002. Revision accepted 15 February 2002.
| LITERATURE CITED |
|---|
|
|
|---|
1. Shils, M. E. (1998) Magnesium. ODell, B. L. Sunde, R. A. eds. Handbook of Nutritionally Essential Mineral Elements 1998:117-152 Marcel Dekker New York, NY. .
2.
Nadler, J. L., Buchanan, T., Natarajan, R., Antonipillai, I., Bergman, R. & Rude, R. K. (1993) Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 21:1024-1029.
3. Rude, R. K. (1993) Magnesium metabolism and deficiency. Endocrinol. Metab. Clin. N. Am. 22:377-395.[Medline]
4. Paolisso, G., Scheen, A., DOnofrio, F. D. & Lefebvre, P. (1990) Magnesium and glucose homeostasis. Diabetologia 33:511-514.[Medline]
5.
Joffres, M. R., Reed, D. M. & Yano, K. (1987) Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am. J. Clin. Nutr. 45:469-475.
6. Ma, J., Folsom, A. R., Melnick, S. L., Eckfeldt, J. H., Sharrett, A. R., Nabulsi, A. A., Hutchinson, R. G. & Metacalf, P.A. (1995) Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Community Study. J. Clin. Epidemiol. 48:927-940.[Medline]
7. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine (1997) Magnesium. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride 1997:190-249 National Academy Press Washington, DC. .
8. Pennington, J.A.T. (2000) Current dietary intakes of trace elements and minerals. Bogden, J. D. Klevay, L. M. eds. Clinical Nutrition of the Essential Trace Elements and Minerals 2000:49-67 Humana Press Totowa, NJ. .
9. Anderson, R. A., Bryden, N. A. & Polansky, M. M. (1993) Dietary intake of calcium, chromium, copper, iron, magnesium, manganese, and zinc: duplicate plate values corrected using derived nutrient intake. J. Am. Diet. Assoc. 93:462-464.[Medline]
10. Rayssiguier, Y., Guezennec, C. Y. & Durlach, J. (1990) New experimental and clinical data on the relationship between magnesium and sport. Magnes. Res. 3:93-102.[Medline]
11. Golf, S. W., Böhmer, D. & Nowacki, P. E. (1994) Is magnesium a limiting factor in competitive exercise? A summary of relevant scientific data. Golf, S. Dralle, D. Vecchiet, L. eds. Magnesium 1993 1994:209-220 John Libbey & Company London, UK. .
12. Brilla, L. R. & Patteson Lombardi, V. (1999) Magnesium in exercise and sport. Driskell, J. Wolinsky, I. eds. Macroelements, Water and Electrolytes 1999:48-90 CRC Press Boca Raton, FL. .
13. Lukaski, H. C. (1999) Vitamin and mineral metabolism and exercise performance. Lamb, D.R. Murray, R. eds. Metabolic Basis of Performance in Exercise and Sport. Perspectives in Exercise Science and Sports Medicine 12:261-314 Cooper Publishing Group Carmel, IN. .
14.
Lukaski, H. C. (2000) Magnesium, zinc and chromium nutriture and physical activity. Am. J. Clin. Nutr. 72(suppl.):585S-593S.
15. Brilla, L. R. & Haley, T. F. (1992) Effect of magnesium supplementation on strength training in humans. J. Am. Coll. Nutr. 11:326-329.[Abstract]
16. Ripari, P., Pieralisi, G., Giamberardino, M. A. & Vecchiet, L. (1989) Effects of magnesium pidolinate on some cardiorespiratory submaximal effort parameters. Magnes. Res. 2:70-74.
17. Brilla, L. R. & Gunther, K. B. (1995) Effect of magnesium supplementation on exercise time to exhaustion. Med. Exerc. Nutr. Health 4:230-233.
18. Manore, M., Merkel, J., Helleksen, J. M., Skinner, J. S. & Carroll, S. S. (1995) Longitudinal changes in magnesium status in untrained males: effect of two different 12-week exercise training programs and magnesium supplementation. Kies, C.V. Driskell, J.A. eds. Sports Nutrition: Minerals and Electrolytes 1995:179-187 CRC Press Boca Raton, FL. .
19. U.S. Department of Agriculture, Agricultural Research Service (1997) Data tables: results from USDAs 199496 Continuing Survey of Food Intakes by Individuals and 199496 Diet and Health Knowledge Survey 1997CD-ROM, NTIS Accession Number PB98500457..
20. U.S. Department of Agriculture, Human Nutrition Information Service (1992) USDA Nutrient Database for Standard Reference. Release 10, (computer tape) 1992 National Technical Information Service Springfield, VA. .
21. Nielsen, F. H. & Milne, D. B. (1999) Calcium balance in postmenopausal women with dietary calcium intakes between 650 and 850 mg/day. FASEB J 13:A869(abs.).
22. Harris, J. A. & Benedict, F. G. (1919) A Biometric Study of Basal Metabolism in Men, Carnegie Publication no. 279 1919 J. P. Lippincott Philadelphia, PA. .
23. Wills, M. R., Sunderman, F. W. & Savory, J. (1986) Methods for the estimation of serum magnesium in clinical laboratories. Magnesium 5:317-327.[Medline]
24. Agarwal, R. P., Chencharick, J. D. & Henkin, R. I. (1985) A simple method for simultaneous estimation of zinc and copper in erythrocytes: comparison of a new methodology with a standard technique. Biol. Trace Elem. Res. 7:199-208.
25. Sims, R. L., Mullen, L. M. & Milne, D. B. (1990) Application of inductively coupled plasma emission spectroscopy to multielement analysis of foodstuffs used in metabolic studies. J. Food Comp. Anal. 3:27-37.
26. Analytical Methods Committee (1960) Methods of destruction of organic matter. Analyst 85:643-656.
27. Bergstrom, J. (1962) Muscle electrolytes in man determined by neutron activation analysis on needle biopsy specimens. A study of normal subjects, kidney patients and patients with chronic diarrhea. Scand. J. Clin. Investig. (suppl.) 68:1-110.
28. Ferrannini, E. (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301.[Medline]
29. Lukaski, H. C. & Bolonchuk, W. W. (1989) Maintenance of aerobic capacity and body composition of volunteers residing on a metabolic research unit. J. Sports Med. Phys. Fitness 29:273-278.[Medline]
30. Lukaski, H. C., Hall, C. B. & Siders, W. A. (1991) Altered metabolic response of iron-deficient women during graded, maximal exercise. Eur. J. Appl. Physiol. 63:140-145.
31. SAS Institute Inc (1999) SAS/STAT Users Guide, version 6 13 SAS Institute Cary, NC. .
32. Seelig, M. S. (1964) The requirement of magnesium by the normal adult. Am. J. Clin. Nutr. 14:342-390.[Abstract]
33. Dunn, M. J. & Walser, M. (1966) Magnesium depletion in normal man. Metabolism 15:884-895.[Medline]
34. Shils, M. E. (1969) Experimental human magnesium depletion. Medicine 48:61-85.[Medline]
35. Lakshmanan, L. F., Rao, R. B., Kim, W. W. & Kelsay, J. L. (1984) Magnesium intakes, balances, and blood levels of adults consuming self-selected diets. Am. J. Clin. Nutr. 40:1380-1389.[Abstract]
36.
Klevay, L. M. & Milne, D. B. (2002) Low dietary magnesium increases supraventricular ectopy. Am. J. Clin. Nutr. 75:550-554.
37. Gatteschi, L., Galvani, P., Orsi, F., Rubenni, M. G. & Resina, A. (1994) Relationships between blood magnesium changes and physical performance. Golf, S. Dralle, D. Vecchiet, L. eds. Magnesium 1993 1994:247-251 John Libbey & Company London, UK. .
38. Dragani, L., Resina, A., Giamberardino, M. A. & Vecchiet, L. (1994) Magnesium and physical activity. Golf, S. Dralle, D. Vecchiet, L. eds. Magnesium 1993 1994:265-272 John Libbey & Company London, UK. .
39. Terblanche, S., Noakes, T. D., Dennis, S. C., Marais, D. W. & Eckert, M. (1992) Failure of magnesium supplementation to influence marathon performance or recovery in magnesium-replete subjects. Int. J. Sports Nutr. 2:154-164.[Medline]
40. Vecchiet, L., Pieralisi, G., DOvidio, M, Dragani, L., Felzani, G., Mincarini, A., Giamberardino, M. A., Borella, P., Bargellini, A. & Piovanelli, P. (1995) Effects of magnesium supplementation on maximal and submaximal effort. Vecchiet, L. eds. Magnesium and Physical Activity 1995:227-237 Parthenon Publishing Group London, UK. .
41. Münch, J. (1992) Einfluß einer Langzietmagnesiumsupplementierung auf Physiologische und Biochemische Parameter unter Wettkampfspezifischen Belastungen bei Ruderern. Doctoral thesis 1992 Justus-Liebig-University Giessen, Germany. .
42. Heaton, F. W. & Elie, J. P. (1984) Metabolic activity of liver mitochondria from magnesium-deficient rats. Magnesium 3:21-28.[Medline]
43.
Vitale, J. J., Nakamura, M. & Hegsted, D. M. (1957) Effect of magnesium deficiency on oxidative phosphorylation. J. Biol. Chem. 228:573-576.
44.
Bergström, M. & Hultman, E. (1988) Energy cost and fatigue during intermittent electrical stimulation of human skeletal muscle. J. Appl. Physiol. 65:1500-1505.
This article has been cited by other articles:
![]() |
F. H. Nielsen, D. B. Milne, L. M. Klevay, S. Gallagher, and L. Johnson Dietary Magnesium Deficiency Induces Heart Rhythm Changes, Impairs Glucose Tolerance, and Decreases Serum Cholesterol in Post Menopausal Women J. Am. Coll. Nutr., April 1, 2007; 26(2): 121 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D Hunt and L. K Johnson Magnesium requirements: new estimations for men and women by cross-sectional statistical analyses of metabolic magnesium balance data. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Feillet-Coudray, C. Coudray, E. Gueux, A. Mazur, and Y. Rayssiguier A New In Vitro Blood Load Test Using a Magnesium Stable Isotope for Assessment of Magnesium Status J. Nutr., April 1, 2003; 133(4): 1220 - 1223. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||